Eric Topol, MD
Founder & Director, Scripps Translational Science Institute
Executive VP & Professor, Molecular Medicine, The Scripps Research Institute
Eric Topol is Executive VP and Professor of Molecular Medicine at The Scripps Research Institute (TSRI), and the Founder and Director of the Scripps Translational Science Institute (STSI). As a researcher, he has published over 1100 peer-reviewed articles, with more than 170,000 citations, elected to the National Academy of Medicine, and is one of the top 10 most cited researchers in medicine (Thomson Reuters ISI, “Doctor of the Decade”). His principal scientific focus has been on the genomic and digital tools to individualize medicine—and the power that brings to individuals to drive the future of medicine.
In 2016, Topol was awarded a $207M grant from the NIH to lead a significant part of the Precision Medicine Initiative, a one million American prospective research program. Prior to coming to lead STSI in 2007, where he is the principal investigator of a flagship $33M NIH grant, he led the Cleveland Clinic to become the #1 center for heart care and was the founder of a new medical school there. He has been voted as the #1 most influential physician leader in the United States in a national poll conducted by Modern Healthcare. Besides editing several textbooks, he has published two bestseller books on the future of medicine: The Creative Destruction of Medicine and The Patient Will See You Now.
Board of Directors: Dexcom, MyoKardia
Co-Founder: Cypher Genomics, Molecular Stethoscope
Scientific Advisory Board: Gilead, Edico Genome, Biological Dynamics, Genapsys
Advisor: Walgreens, Illumina, Google, Apple, Blue Cross/Blue Shield, Quanttus, ToSense